[Physiopathology and curative treatment of tardive dyskinesia].
作者信息
Wolf M A, Gautier J
机构信息
Unité de Neuropsychopharmácologie, Centre Hospitalier Robert Giffard, Beauport, Qué., Canada.
出版信息
Encephale. 1987 Sep-Oct;13(5):301-8.
PMID:2892663
Abstract
Tardive dyskinesia is a common complication of neuroleptic treatment. Current physiopathological theories emphasize the role of dopaminergic, cholinergic and GABAergic systems. The experimental bases of these hypotheses have been presented in detail. A critical review of the main clinical trials allows us to evaluate the effectiveness of our treatment and the validity of our theoretical models.
摘要
相似文献
1
[Physiopathology and curative treatment of tardive dyskinesia].
Encephale. 1987 Sep-Oct;13(5):301-8.
2
Tardive dyskinesia: pathophysiology and animal models.迟发性运动障碍：病理生理学与动物模型
J Clin Psychiatry. 2000;61 Suppl 4:5-9.
3
4
Tardive dyskinesia and essential fatty acids.迟发性运动障碍与必需脂肪酸
Int Rev Psychiatry. 2006 Apr;18(2):133-43. doi: 10.1080/09540260600583114.
5
Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.迟发性运动障碍。病理生理机制与临床试验。
Encephale. 1988 Sep;14 Spec No:227-32.
6
Animal models of tardive dyskinesia--a review.迟发性运动障碍的动物模型——综述
Indian J Physiol Pharmacol. 2001 Apr;45(2):148-60.
7
[Late dyskinesia: experimental models, paradoxes and deductions].[迟发性运动障碍：实验模型、悖论与推论]
Agressologie. 1987 Sep;28(8):827-30.
8
Neuroleptic-induced tardive dyskinesia.抗精神病药物所致迟发性运动障碍
Acta Psychiatr Belg. 1987 Sep-Oct;87(5):566-98.
9
10
Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.孕酮通过其代谢产物别孕烯醇酮（一种对GABA(A)具有正向调节作用的神经甾体）的活性减轻抗精神病药物引起的口面部运动障碍。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):451-61. doi: 10.1016/j.pnpbp.2007.09.017. Epub 2007 Sep 29.
Zotero 插件